SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-076494
Filing Date
2024-03-25
Accepted
2024-03-25 16:10:36
Documents
16
Period of Report
2024-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d802072d8k.htm   iXBRL 8-K 27319
2 EX-99.1 d802072dex991.htm EX-99.1 80362
7 GRAPHIC g802072g41w18.jpg GRAPHIC 3998
  Complete submission text file 0001193125-24-076494.txt   290378

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eftr-20240325.xsd EX-101.SCH 4335
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20240325_def.xml EX-101.DEF 14095
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20240325_lab.xml EX-101.LAB 23584
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20240325_pre.xml EX-101.PRE 15128
19 EXTRACTED XBRL INSTANCE DOCUMENT d802072d8k_htm.xml XML 5995
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 24779313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)